康龙化成:季报点评:3Q业绩环比改善,CMC新签订单增速较快
PHARMARON(300759) 中原证券·2024-11-08 12:01
其他医药医疗 分析师:李琳琳 登记编码:S0730511010010 lill@ccnew.com 021-50586983 3Q 业绩环比改善,CMC 新签订单增速较快 ——康龙化成(300759)季报点评 | --- | --- | --- | |--------------------------------------|------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...